Covid 19: Evaluation of SARS-CoV-2 Positivity, Genetic Risk Factors & Outcomes in Patients Enrolled in TCC

Grants and Contracts Details

StatusActive
Effective start/end date10/27/207/1/23

Funding

  • M2Gen Corporation: $374,000.00